RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
STERIS plc Stock

STERIS plc Revenue 2025

STERIS plc Revenue

5.55 B USD

Ticker

STE

ISIN

IE00BFY8C754

WKN

A2PGLV

In 2025, STERIS plc's sales reached 5.55 B USD, a 7.93% difference from the 5.14 B USD sales recorded in the previous year.

The STERIS plc Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2029e7.0731,37
2028e6.733,09
2027e6.2735,38
2026e5.937,60
2025e5.5540,00
20245.1443,17
20234.9643,56
20224.5943,98
20213.1143,22
20203.0343,55
20192.7842,23
20182.6241,71
20172.6139,28
20162.2440,00
20151.8541,85
20141.6240,04
20131.541,37
20121.4140,41
20111.2136,96
20101.2642,83
20091.340,56
20081.2740,36
20071.241,11
20061.1641,73
20051.0842,70

STERIS plc Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into STERIS plc, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by STERIS plc from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects STERIS plc’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of STERIS plc. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into STERIS plc’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing STERIS plc’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on STERIS plc’s growth potential.

STERIS plc Revenue, EBIT and net profit per share

DateSTERIS plc RevenueSTERIS plc EBITSTERIS plc Net Income
2029e7.07 B undefined0 undefined1.12 B undefined
2028e6.7 B undefined0 undefined1.05 B undefined
2027e6.27 B undefined1.45 B undefined1.07 B undefined
2026e5.9 B undefined1.35 B undefined990.79 M undefined
2025e5.55 B undefined1.23 B undefined903.94 M undefined
20245.14 B undefined887.69 M undefined378.24 M undefined
20234.96 B undefined783.4 M undefined107 M undefined
20224.59 B undefined425.6 M undefined243.9 M undefined
20213.11 B undefined545.5 M undefined397.4 M undefined
20203.03 B undefined537.7 M undefined407.7 M undefined
20192.78 B undefined458.2 M undefined303.7 M undefined
20182.62 B undefined401.4 M undefined290.9 M undefined
20172.61 B undefined286.7 M undefined110 M undefined
20162.24 B undefined212.8 M undefined110.8 M undefined
20151.85 B undefined228.3 M undefined135.1 M undefined
20141.62 B undefined221.2 M undefined129.4 M undefined
20131.5 B undefined242.4 M undefined160 M undefined
20121.41 B undefined223 M undefined136.1 M undefined
20111.21 B undefined106.3 M undefined51.3 M undefined
20101.26 B undefined208.1 M undefined128.5 M undefined
20091.3 B undefined179 M undefined110.7 M undefined
20081.27 B undefined139 M undefined77.1 M undefined
20071.2 B undefined144.3 M undefined82.2 M undefined
20061.16 B undefined135 M undefined70.3 M undefined
20051.08 B undefined141.3 M undefined86 M undefined

STERIS plc stock margins

The STERIS plc margin analysis displays the gross margin, EBIT margin, as well as the profit margin of STERIS plc. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for STERIS plc.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the STERIS plc's sales revenue. A higher gross margin percentage indicates that the STERIS plc retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the STERIS plc's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the STERIS plc's total revenue generated. When comparing the revenue margin year over year, investors can gauge the STERIS plc's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the STERIS plc. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the STERIS plc's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

STERIS plc Margin History

STERIS plc Gross marginSTERIS plc Profit marginSTERIS plc EBIT marginSTERIS plc Profit margin
2029e43.17 %0 %15.81 %
2028e43.17 %0 %15.72 %
2027e43.17 %23.17 %17.03 %
2026e43.17 %22.89 %16.8 %
2025e43.17 %22.16 %16.3 %
202443.17 %17.27 %7.36 %
202343.56 %15.8 %2.16 %
202243.98 %9.28 %5.32 %
202143.22 %17.55 %12.79 %
202043.55 %17.74 %13.45 %
201942.23 %16.47 %10.92 %
201841.71 %15.32 %11.1 %
201739.28 %10.97 %4.21 %
201640 %9.51 %4.95 %
201541.85 %12.34 %7.3 %
201440.04 %13.63 %7.98 %
201341.37 %16.14 %10.65 %
201240.41 %15.85 %9.67 %
201136.96 %8.8 %4.25 %
201042.83 %16.55 %10.22 %
200940.56 %13.79 %8.53 %
200840.36 %10.99 %6.09 %
200741.11 %12.05 %6.86 %
200641.73 %11.63 %6.06 %
200542.7 %13.06 %7.95 %

STERIS plc Aktienanalyse

What does STERIS plc do?

Steris plc is a global provider of products and services in the field of sterilization and disinfection. The company was founded in the United States in 1985 and became an Irish company with headquarters in Dublin in 2015. Steris plc's business model is based on offering solutions for the sterilization and disinfection of medical devices, rooms, and instruments. The company offers a wide range of products and services, including machines and equipment, chemicals and consumables, as well as consulting and training services. Steris plc is divided into several business segments, each focused on specific customer needs. The Healthcare Products division provides solutions for hospitals and medical facilities, including cleaning and disinfecting agents, surgical instruments, and sterilization equipment. The Life Sciences division offers products and services for biotechnology, pharmaceutical, and medical device companies, such as cleaning and sterilization services that comply with FDA regulations. Another important area of Steris plc is Applied Sterilization Technologies, which offers customized solutions for customers in various industries. These range from sterilizing food and beverages to industrial applications such as sterilizing materials in the automotive industry. In addition to offering products and services, Steris plc also specializes in consulting and training for customers. The company provides a wide range of training and seminars to ensure optimal use of sterilization and disinfection products and maximize safety and efficiency. One of Steris plc's most well-known products is the "STERIS V-PRO" system. This system is an automated sterilizer that allows for rapid sterilization of medical instruments and devices. Unlike traditional sterilization methods, this system uses high-energy waves for sterilization, making it possible to sterilize sensitive instruments and materials that may not be possible with conventional methods. Another product of Steris plc is the "SYSTEM 1" sterilization process, used for the sterilization of flexible endoscopes. This process is particularly efficient and effective, sterilizing the endoscopes quickly and thoroughly without causing damage during the process. Steris plc is a pioneer in the field of sterilization and disinfection and has established itself as a leading provider in this field. The company aims to develop innovative solutions to help customers worldwide meet their sterilization and disinfection requirements optimally. STERIS plc ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding STERIS plc's Sales Figures

The sales figures of STERIS plc originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing STERIS plc’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize STERIS plc's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in STERIS plc’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about STERIS plc stock

How much revenue did STERIS plc generate this year?

STERIS plc has achieved a revenue of 5.55 B USD this year.

How much was the turnover of the company STERIS plc compared to the previous year?

The revenue of STERIS plc has increased by 7.93% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of STERIS plc?

The revenue of STERIS plc is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of STERIS plc measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of STERIS plc so important for investors?

The revenue of STERIS plc is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does STERIS plc pay?

Over the past 12 months, STERIS plc paid a dividend of 2.18 USD . This corresponds to a dividend yield of about 1.06 %. For the coming 12 months, STERIS plc is expected to pay a dividend of 2.22 USD.

What is the dividend yield of STERIS plc?

The current dividend yield of STERIS plc is 1.06 %.

When does STERIS plc pay dividends?

STERIS plc pays a quarterly dividend. This is distributed in the months of March, July, October, December.

How secure is the dividend of STERIS plc?

STERIS plc paid dividends every year for the past 25 years.

What is the dividend of STERIS plc?

For the upcoming 12 months, dividends amounting to 2.22 USD are expected. This corresponds to a dividend yield of 1.08 %.

In which sector is STERIS plc located?

STERIS plc is assigned to the 'Health' sector.

Wann musste ich die Aktien von STERIS plc kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of STERIS plc from 12/19/2024 amounting to 0.57 USD, you needed to have the stock in your portfolio before the ex-date on 11/19/2024.

When did STERIS plc pay the last dividend?

The last dividend was paid out on 12/19/2024.

What was the dividend of STERIS plc in the year 2024?

In the year 2024, STERIS plc distributed 1.98 USD as dividends.

In which currency does STERIS plc pay out the dividend?

The dividends of STERIS plc are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von STERIS plc

Our stock analysis for STERIS plc Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of STERIS plc Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.